Physiological functions of Pten in mouse tissues

Cell Structure and Function

Volumn 28, Issue 1, 2003, Pages 11-21

  Kishimoto, Hiroyuki ^a   Hamada, Koichi ^a   Saunders, Mary ^b   Backman, Stephanie ^b   Sasaki, Takehiko ^c   Nakano, Toru ^d   Mak, Tak Wah ^b   Suzuki, Akira ^a  

^a AKITA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Cre loxP system; Pten; Tissue specific mutant mice

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL TISSUE; APOPTOSIS; B LYMPHOCYTE; BRAIN CELL; BREAST CELL; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; COWDEN SYNDROME; ENZYME ACTIVATION; GENE EXPRESSION; GENE MUTATION; GLUCOSE METABOLISM; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; KERATINOCYTE; LHERMITTE DUCLOS DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0037310664     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.28.11     Document Type: Review

References (85)

1. Ackler, S., Ahmad, S., Tobias, C., Johnson, M.D., and Glazer, R.I. 2002. Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene, 21: 198-206.
2. Babb T, B.W. 1987. Pathological findings in epilepsy. In Surgical Treatment of Epilepsies (ed. Engel, J.) 511-540 (Raven Press, New York).
3. Backman, S.A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M.S., Shannon, P., Bolon, B., Ivy, G.O., and Mak, T.W. 2001. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet., 29: 396-403.
4. Bol, D.K., Kiguchi, K., Gimenez-Conti, I., Rupp, T., and DiGiovanni, J. 1997. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene, 14: 1725-1734.
5. Borlado, L.R., Redondo, C., Alvarez, B., Jimenez, C., Criado, L.M., Flores, J., Marcos, M.A., Martinez, A.C., Balomenos, D., and Carrera, A.C. 2000. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. Faseb J., 14: 895-903.
6. +) B cells to secrete IgG1 and IgG3. J. Exp. Med., 179: 757-762.
7. Butler, M., McKay, R.A., Popoff, I.J., Gaarde, W.A., Witchell, D., Murray, S.F., Dean, N.M., Bhanot, S., and Monia, B.P. 2002. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes, 51: 1028-1034.
8. Camisa, C., Bikowski, J.B., and McDonald, S.G. 1984. Cowden's disease. Association with squamous cell carcinoma of the tongue and perianal basal cell carcinoma. Arch. Dermatol., 120: 677-678.
9. Clayton, E., Bardi, G., Bell, S.E., Chantry, D., Downes, C.P., Gray, A., Humphries, L.A., Rawlings, D., Reynolds, H., Vigorito, E., and Turner, M. 2002. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med., 196: 753-763.
10. Crackower, M.A., Oudit, G.Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., and Irie-Sasaki, J. et al. 2002. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell, 110: 737-749.
11. Dammers, P.M., de Boer, N.K., Deenen, G.J., Nieuwenhuis, P., and Kroese, F.G. 1999. The origin of marginal zone B cells in the rat. Eur. J. Immunol., 29: 1522-1531.
12. +/- mice. Science, 285: 2122-2125.
13. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P.P. 1998. Pten is essential for embryonic development and tumour suppression. Nat. Genet., 19: 348-355.
14. DiGiovanni, J., Bol, D.K., Wilker, E., Beltran, L., Carbajal, S., Moats, S., Ramirez, A., Jorcano, J., and Kiguchi, K. 2000. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res., 60: 1561-1570.
15. Dominey, A.M., Wang, X.J., King, L.E., Jr., Nanney, L.B., Gagne, T.A., Sellheyer, K., Bundman, D.S., Longley, M.A., Rothnagel, J.A., and Greenhalgh, D.A. et al. 1993. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ., 4: 1071-1082.
16. Esser, C. and Radbruch, A. 1989. Rapid induction of transcription of unrearranged S gamma 1 switch regions in activated murine B cells by interleukin 4. Embo J., 8: 483-488.
17. Fagarasan, S. and Honjo, T. 2000. T-Independent immune response: new aspects of B cell biology. Science, 290: 89-92.
18. Fruman, D.A., Snapper, S.B., Yballe, C.M., Davidson, L., Yu, J.Y., Alt, F.W., and Cantley, L.C. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science, 283: 393-397.
19. Fukui, Y., Hashimoto, O., Sanui, T., Oono, T., Koga, H., Abe, M., Inayoshi, A., Noda, M., Oike, M., Shirai, T., and Sasazuki, T. 2001. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature, 412: 826-831.
20. Gat, U., DasGupta, R., Degenstein, L., and Fuchs, E. 1998. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell, 95: 605-614.
21. Gille, H. and Downward, J. 1999. Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem., 274: 22033-22040.
22. Girkontaite, I., Missy, K., Sakk, V., Harenberg, A., Tedford, K., Potzel, T., Pfeffer, K., and Fischer, K.D. 2001. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol., 2: 855-862.
23. Goberdhan, D.C., Paricio, N., Goodman, E.C., Mlodzik, M., and Wilson, C. 1999. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev., 13: 3244-3258.
24. Greenhalgh, D.A., Rothnagel, J.A., Quintanilla, M.I., Orengo, C.C., Gagne, T.A., Bundman, D.S., Longley, M.A., and Roop, D.R. 1993. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog., 7: 99-110.
25. Gronbaek, K., Zeuthen, J., Guldberg, P., Ralfkiaer, E., and Hou-Jensen, K. 1998. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood, 91: 4388-4390.
26. Groszer, M., Erickson, R., Scripture-Adams, D.D., Lesche, R., Trumpp, A., Zack, J.A., Kornblum, H.I., Liu, X., and Wu, H. 2001. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science, 294: 2186-2189.
27. Guinamard, R., Okigaki, M., Schlessinger, J., and Ravetch, J.V. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol., 1: 31-36.
28. Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., and Stokoe, D. 1998. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol., 8: 1195-1198.
29. Hadari, Y.R., Tzahar, E., Nadiv, O., Rothenberg, P., Roberts, C.T., Jr., LeRoith, D., Yarden, Y., and Zick, Y. 1992. Insulin and insulino-mimetic agents induce activation of phosphatidylinositol 3′-kinase upon its association with pp185 (IRS-1) in intact rat livers. J. Biol. Chem., 267: 17483-17486.
30. Hildenbrand, C., Burgdorf, W.H., and Lautenschlager, S. 2001. Cowden syndrome-diagnostic skin signs. Dermatology, 202: 362-366.
31. Hu, P., Margolis, B., Skolnik, E.Y., Lammers, R., Ullrich, A., and Schlessinger, J. 1992. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell Biol., 12: 981-990.
32. Huang, H., Potter, C.J., Tao, W., Li, D.M., Brogiolo, W., Hafen, E., Sun, H., and Xu, T. 1999. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development, 126: 5365-5372.
33. Hutchinson, J., Jin, J., Cardiff, R.D., Woodgett, J.R., and Muller, W.J. 2001. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell Biol., 21: 2203-2212.
34. Hyun, T., Yam, A., Pece, S., Xie, X., Zhang, J., Miki, T., Gutkind, J.S., and Li, W. 2000. Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood, 96: 3560-3568.
35. Jones, R.G., Parsons, M., Bonnard, M., Chan, V.S., Yeh, W.C., Woodgett, J.R., and Ohashi, P.S. 2000. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med., 191: 1721-1734.
36. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature, 349: 245-248.
37. + thymocytes. Nature, 333: 742-746.
38. Kwon, C.H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart, C.G., Burger, P.C., and Baker, S.J. 2001. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat. Genet., 29: 404-411.
39. Li, G., Robinson, G.W., Lesche, R., Martinez-Diaz, H., Jiang, Z., Rozengurt, N., Wagner, K.U., Wu, D.C., Lane, T.F., and Liu, X. et al. 2002. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development, 129: 4159-4170.
40. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., and McCombie, R. et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275: 1943-1947.
41. Li, Y., Podsypanina, K., Liu, X., Crane, A., Tan, L.K., Parsons, R., and Varmus, H.E. 2001. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol. Biol., 2: 2.
42. Liao, X.C. and Littman, D.R. 1995. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity, 3: 757-769.
43. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., and Peacocke, M. et al. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67.
44. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J., and Efstratiadis, A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell, 75: 59-72.
45. Maehama, T. and Dixon, J.E. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273: 13375-13378.
46. Marino, S., Krimpenfort, P., Leung, C., van der Korput, H.A., Trapman, J., Camenisch, I., Berns, A., and Brandner, S. 2002. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development, 129: 3513-3522.
47. Marsh, D.J., Dahia, P.L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R.J., and Eng, C. 1997. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334.
48. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and Honjo, T. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 102: 553-563.
49. Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarov, J.P., Hemmings, B.A., Wigler, M.H., Downes, C.P., and Tonks, N.K. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA, 95: 13513-13518.
50. Naga Prasad, S.V., Esposito, G., Mao, L., Koch, W.J., and Rockman, H.A. 2000. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J. Biol. Chem., 275: 4693-4698.
51. Nakahara, Y., Nagai, H., Kinoshita, T., Uchida, T., Hatano, S., Murate, T., and Saito, H. 1998. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma. Leukemia, 12: 1277-1280.
52. Nuss, D.D., Aeling, J.L., Clemons, D.E., and Weber, W.N. 1978. Multiple hamartoma syndrome (Cowden's disease). Arch. Dermatol., 114: 743-746.
53. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S.E., Salpekar, A., and Waterfield, M.D. et al. 2002. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science, 297: 1031-1034.
54. Parsons, M.J., Jones, R.G., Tsao, M.S., Odermatt, B., Ohashi, P.S., and Woodgett, J.R. 2001. Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. J. Immunol., 167: 42-48.
55. Persad, S., Troussard, A.A., McPhee, T.R., Mulholland, D.J., and Dedhar, S. 2001. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol., 153: 1161-1174.
56. Podsypanina, K., Ellenson, L.H., Nemes, A., Gu, J., Tamura, M., Yamada, K.M., Cordon-Cardo, C., Catoretti, G., Fisher, P.E., and Parsons, R. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA, 96: 1563-1568.
57. Ponzetto, C., Bardelli, A., Maina, F., Longati, P., Panayotou, G., Dhand, R., Waterfield, M.D., and Comoglio, P.M. 1993. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell Biol., 13: 4600-4608.
58. Raffioni, S. and Bradshaw, R.A. 1992. Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. Proc. Natl. Acad. Sci. USA, 89: 9121-9125.
59. Rho, O., Bol, D.K., You, J., Beltran, L., Rupp, T., and DiGiovanni, J. 1996. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin. Mol. Carcinog., 17: 62-69.
60. Sasaki, T., Irie-Sasaki, J., Jones, R.G., Oliveira-dos-Santos, A.J., Stanford, W.L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., and Kozieradzki, I. 2000. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science, 287: 1040-1046.
61. Scanga, S.E., Ruel, L., Binari, R.C., Snow, B., Stambolic, V., Bouchard, D., Peters, M., Calvieri, B., Mak, T.W., Woodgett, J.R., and Manoukian, A.S. 2000. The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene, 19: 3971-3977.
62. Schwartzbauer, G. and Robbins, J. 2001. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem., 276: 35786-35793.
63. Schwertfeger, K.L., Richert, M.M., and Anderson, S.M. 2001. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol. Endocrinol., 15: 867-881.
64. Segrelles, C., Ruiz, S., Perez, P., Murga, C., Santos, M., Budunova, I.V., Martinez, J., Larcher, F., Slaga, T.J., and Gutkind, J.S. et al. 2002. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene, 21: 53-64.
65. Shan, X., Czar, M.J., Bunnell, S.C., Liu, P., Liu, Y., Schwartzberg, P.L., and Wange, R.L. 2000. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell Biol., 20: 6945-6957.
66. Sharp, L.L. and Hedrick, S.M. 1999. Commitment to the CD4 lineage mediated by extracellular signal-related kinase mitogen-activated protein kinase and lck signaling. J. Immunol., 163: 6598-6605.
67. Shioi, T., McMullen, J.R., Kang, P.M., Douglas, P.S., Obata, T., Franke, T.F., Cantley, L.C., and Izumo, S. 2002. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell Biol., 22: 2799-2809.
68. Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F.M., Schlessinger, J., and Wagner, E.F. 2000. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell, 102: 211-220.
69. Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P., and Mak, T.W. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95: 29-39.
70. +/- mice. Cancer Res., 60: 3605-3611.
71. Stephens, L.R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A.S., Thelen, M., Cadwallader, K., Tempst, P., and Hawkins, P.T. 1997. The Gbg sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell, 89: 105-114.
72. Stoyanov, B., Volinia, S., Hanck, T., Rubio, I., Loubtchenkov, M., Malek, D., Stoyanova, S., Vanhaesebroeck, B., Dhand, R., and Nurnberg, B. 1995. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science, 269: 690-693.
73. Suzuki, A., Itami, S., Ohishi, M., Yamaguchi, M.T., Hamada, K., Inoue, T., Komazawa, N., Senoo, H., Sasaki, T., Takeda, J., Manabe, M., Mak, T.W., and Nakano, T. 2003 in revision. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res., 63: 674-681.
74. Suzuki, A., de la Pompa, J.L., Stambolic, V., Elia, A.J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., and Khoo, W. et al. 1998. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol., 8: 1169-1178.
75. Suzuki, A., Kaisho, T., Ohishi, M., Tsukio-Yamguchi, M., Tsubata, T., Koni, P.A., Sasaki, T., Mak, T.W., and Nakano, T. 2003. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med, in press.
76. Suzuki, A., Yamaguchi, M.T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., and Fukumoto, M. et al. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity, 14: 523-534.
77. Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T., and Koyasu, S. 1999. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science, 283: 390-392.
78. Toker, A. and Cantley, L.C. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature, 387: 673-676.
79. Tsukamoto, A.S., Grosschedl, R., Guzman, R.C., Parslow, T., and Varmus, H.E. 1988. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55: 619-625.
80. Valentinis, B., Navarro, M., Zanocco-Marani, T., Edmonds, P., McCormick, J., Morrione, A., Sacchi, A., Romano, G., Reiss, K., and Baserga, R. 2000. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J. Biol. Chem., 275: 25451-25459.
81. Vassar, R. and Fuchs, E. 1991. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev, 5: 714-27.
82. Vassar, R., Hutton, M.E., and Fuchs, E. 1992. Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol. Cell Biol., 12: 4643-4653.
83. Wiestler, O.D., Padberg, G.W., and Steck, P.A. 2000. Cowen disease and dysplastic gangliocytoma of the cerebellum/Lhermitte-Duclos disease. In Pathology and Genetics of Tumors of the Nervous System (eds. Kleihues, P. & Cavenee, W.K.) 235-237 (IARC Press, Lyon).
84. Yamamoto, K., Lapetina, E.G., and Moxham, C.P. 1992. Insulin like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor. Endocrinology, 130: 1490-1498.
85. Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., and Pastan, I. et al. 1986. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46: 414-416.